Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Novotel Mumbai Juhu Beach

Sep 24, 2024 8:00 AM - Sep 25, 2024 6:00 PM

Balraj Sahni Marg, Juhu Beach, Mumbai 400049, India

DIA India Annual Meeting 2024

Confluence of Care: Pharmacovigilance, Clinical Innovation, Regulatory Sciences, and Medical Devices Elevating Patient Safety

Early Bird ending in

DAYS

HOURS

MINUTES

SECONDS

Overview

The 2024 DIA India Annual Meeting is an occasion for industry professionals, regulatory authorities, and decision-makers to convene in one place and discuss the current healthcare landscape in India. This year, we are excited to introduce a new feature with three specialized tracks focusing on medical devices, pharmacovigilance, and clinical topics. These tracks will provide in-depth exploration and discussion on key areas of interest within each field, allowing attendees to gain valuable insights and network with experts in their respective domains.

Additionally, the meeting will continue to serve as a platform for decision-makers to align, share challenges and opportunities, and hear from experts about their vision for the future. Expect thought-provoking discussions on current issues like AI, an exchange of innovative ideas between diverse stakeholders, and the potential for strategic collaborations.

Featured topics

  • Clinical: a focus on the role of technology and AI in healthcare.
  • Medical Devices: Expect a discussion on development, clinical data, and the challenges and opportunities from upcoming regulations.
  • Pharmacovigilance: Exploration of key regulatory, clinical, and vigilance strategies for medical devices, risk mitigation strategies of chemotherapeutic agents, and more.
  • Hot Topics/Current Issues: From acquisitions and mergers to AI in PV, clinical development, and regulatory sciences.

Who should attend?

  • Pharmacovigilance And Drug Safety
  • Risk Management
  • Clinical Professionals
  • Medical Writing
  • Pharmacovigilance Compliance
  • Regulatory Affairs
  • Medical Affairs
  • Clinical Research
  • Medical Devices
  • Late Phase Professionals Conducting PMS, Observational And Non-Interventional Studies
  • Real World Data And Real World Evidence
  • Technology Professionals

Learning objectives

Attendees of the 2024 DIA India Annual Meeting can expect to:

  • Gain insights into the changing landscape of the healthcare industry in India.
  • Understand the challenges and opportunities presented by upcoming regulations in the field of medical devices.
  • Discuss challenges and opportunities in patient engagement, regulatory affairs, and pharmacology, among others.
  • Engage in insightful dialogues with industry professionals and decision-makers.
  • Network with key stakeholders and potential collaborators in healthcare.

Program Committee

  • Moin  Don
    Moin Don Adjunct Professor, Jamia Hamdard University, Dept of Pharmacology, School of
    Pharmacy, Lead : South Asia Chapter – ISoP, Founder & CEO, PV Consulting, India
  • Ashish  Indani
    Ashish Indani Senior Manager – Clinical Affairs Neurovascular
    Stryker Global Technology Center, India
  • Fahd  Khan
    Fahd Khan Director Business Development
    OrciMed Life Science Private Limited, India
  • Prashant  Joshi, RPh
    Prashant Joshi, RPh Executive Director - Drug Safety
    Fortrea, India
  • Ritu  Jaswal
    Ritu Jaswal Vice President - Pharmacovigilance Operations
    Parexel, India
  • Shadab  Makhdoomi
    Shadab Makhdoomi Associate Vice President
    Accenture Life Sciences, India
  • Sonica Sachdeva Batra, DrMed
    Sonica Sachdeva Batra, DrMed AVP & Head – Regulatory Solutions
    Indegene, India
  • J Vijay  Venkatraman, MD, MBA
    J Vijay Venkatraman, MD, MBA Managing Director and CEO
    Oviya MedSafe, India
  • Vijay  Bhargav
    Vijay Bhargav Vice President, Lifecycle Safety
    IQVIA, India
  • Swapnali  Raut
    Swapnali Raut Director, Clinical Operations, Global Monitoring and Site Engagement (GMASE)
    Global Clinical Operations Development – R&D, GSK, India
  • Pramod  Kashid
    Pramod Kashid CEO
    Expecto Health Science, Singapore
  • Manjusha  Rajarshi
    Manjusha Rajarshi Founder Regulus Healthcare
    Partner at roots-simplified Research and Consulting LLP, India
  • Manish  Paliwal
    Manish Paliwal Director, Regulatory Affairs
    Pfizer, Inc., India
  • Omprakash  Sadhwani
    Omprakash Sadhwani Ex-Joint Commissioner (HQ) and Drugs Controller
    Maharashtra Food and Drug Administration, India
  • Priyadarshini  Arambam
    Priyadarshini Arambam Academics & Research Department - Batra Hospital and Medical Research Centre
    General Manager - Clinical Research Operations, India
  • Susan  Korah
    Susan Korah Head - Delivery, Digital Health and Wellness
    Tata Consultancy Services, India

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.